THRN — Thorne HealthTech Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousMid Cap
- $550.63m
- $563.26m
- $228.73m
Thorne Healthtech Inc expected to post earnings of 8 cents a share - Earnings Preview
Thorne Healthtech Inc reports results for the quarter ended in December - Earnings Summary
Brief: Thorne Healthtech Reports Fourth Quarter And Full-Year 2022 Results
Brief: Thorne HealthTech Appoints Saloni Varma As New Chief Financial Officer
Brief: Thorne Healthtech Acquires Precon Health
Brief: Healthtech Inc Announces U.S. Appeals Court Final Ruling On Nicotinamide Riboside Intellectual Property Claim
Brief: Thorne Healthtech Announces Resignation Of Bryan Conley As CFO
Brief: Thorne Healthtech's Onedraw Device Used In Department Of Defense's Cancer Moonshot 2.0 Project, Prometheus, As Part Of President Biden Initiative
U.S. RESEARCH ROUNDUP- Allete, Cisco, Yeti Holdings
Thorne Healthtech Inc reports results for the quarter ended in September - Earnings Summary
Brief: Thorne Healthtech Reports Third Quarter 2022 Results
Thorne Healthtech Inc expected to post earnings of 14cents a share - Earnings Preview
Brief: Thorne Healthtech And Gentegra Collaborate To Develop A Next-Generation Whole Blood Dna Collection And Extraction Kit
Brief: Thorne Healthtech's OneDraw Blood Collection Device Receives PMDA Certification In Japan
Brief: Thorne Healthtech Q2 Adjusted Loss Per Share $0.05
Brief: Thorne HealthTech Announces Two-Year Collaboration With AstraZeneca
Brief: Thorne Healthtech Achieves Self-Affirmed Gras Status For Nicotinamide Riboside Malate
Brief: Thorne HealthTech Reports First Quarter 2022 Results
Brief: Thorne Healthtech Inc - On March 21, Board Appointed Bryan K. Conley As CFO Effective On April 1, 2022